Accuracy of a prediction model for heparin-induced thrombocytopenia (HIT): An analysis based on individual patient data

被引:3
|
作者
Garcia Junqueira, Daniela Rezende [1 ]
Viana, Thercia Guedes [1 ]
Carvalho, Maria das Gracas [2 ]
Perini, Edson [1 ]
机构
[1] Univ Fed Minas Gerais, Ctr Drug Studies Cemed, Dept Social Pharm, Sch Pharm, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Sch Pharm, Belo Horizonte, MG, Brazil
关键词
Heparin; Adverse drug reaction; Diagnosis; Thrombocytopenia; Diagnostic test accuracy; Algorithm; OPERATING CHARACTERISTIC CURVES; DIAGNOSIS; ANTIBODIES; MANAGEMENT; ASSAY;
D O I
10.1016/j.cca.2011.04.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction associated with thrombosis, and its paradoxical nature is a challenging issue for the diagnosis. The '4Ts' scoring system represents a simple and efficient way to improve clinical diagnoses of the syndrome. This system classifies patients as having high, intermediate, and low clinical probability for HIT. However, uncertainty remains concerning its clinical meaning, thus weakening the diagnostic value of this screening instrument. Methods: We analyzed the diagnostic test accuracy based on individual patient data extracted from published primary scientific studies. This study focused on 186 cases of treatment with heparin, which later evolved into a clinical suspicion of HIT. Upon choosing the most appropriate reference laboratory, the accuracy of the 4Ts was analyzed using the receiver operator characteristic curve analysis. Results: Half of the positive cases (57.1%) were classified as having a high score, while 25.5% of the negative cases were classified as a having low score for HIT. Slightly more than half of all patients (53.2%) were classified as having an intermediate score. As such, the pre-test instrument would most likely fail to distinguish between diseased and nondiseased patients in a relevant number of cases. The calculated accuracy of the summary indicates that the 4Ts can be considered a good, but not a defining, test. Conclusion: Further studies are warranted regarding clinical score systems, either alone or in combination with laboratory tests, in an attempt to improve the early diagnosis of this adverse drug reaction and to provide better care for at-risk patients. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1521 / 1526
页数:6
相关论文
共 50 条
  • [31] Heparin-induced thrombocytopenia and the health economic analysis of argatroban
    Coventry, D. A.
    Webster, N. R.
    BRITISH JOURNAL OF ANAESTHESIA, 2014, 112 (06) : 964 - 967
  • [32] Research on clinical characteristics and prognostic analysis of heparin-induced thrombocytopenia after surgery for acute type a aortic dissection
    Zhou, Chu-zhi
    Feng, Dong-jie
    Fang, Yuan
    Zha, Feng-yan
    Wang, Er-hui
    Li, Yan-zhen
    Wei, Min-xin
    Wen, Jun-min
    JOURNAL OF CARDIOTHORACIC SURGERY, 2021, 16 (01)
  • [33] Heparin-induced thrombocytopenia (HIT). Importance for anesthesia and intensive care medicine
    Kleinschmidt, S
    Seyfert, UT
    ANAESTHESIST, 1999, 48 (11): : 771 - 785
  • [34] Performance of 4T score and heparin–platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer
    Myra Wong
    Thein Hlaing Oo
    Wei Qiao
    Naveen Garg
    Cristhiam M. Rojas-Hernandez
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 261 - 266
  • [35] Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia A systematic review and meta-analysis
    Sun, Lova
    Gimotty, Phyllis A.
    Lakshmanan, Suvasini
    Cuker, Adam
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 1044 - 1055
  • [36] Thumb Microthrombosis/Necrosis in a Patient with Heparin-induced Thrombocytopenia
    Lucic, Josip
    Bakchoul, Tamam
    Althaus, Karina
    TRANSFUSIONSMEDIZIN, 2020, 10 (01) : 25 - 28
  • [37] Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: a retrospective analysis
    Zaman, Sameer
    Wiebe, Stefan
    Bernal, William
    Wendon, Julia
    Czuprynska, Julia
    Auzinger, Georg
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (08) : 967 - 971
  • [38] Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II
    Wellborn-Kim, Jennifer J.
    Mitchell, George A.
    Terneus, William F., Jr.
    Stowe, Cary L.
    Malias, Mark A.
    Sparkman, Gary M.
    Hanson, Greer W.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (13) : 1075 - 1079
  • [39] Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT)
    Sachs, Ulrich J.
    von Hesberg, Jakob
    Santoso, Sentot
    Bein, Gregor
    Bakchoul, Tamam
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 1197 - 1202
  • [40] Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer
    Wong, Myra
    Oo, Thein Hlaing
    Qiao, Wei
    Garg, Naveen
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (02) : 261 - 266